APO Research
Talk to an analyst

APO RESEARCH · REPORT

Estradiol Transdermal Patches

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Estradiol Transdermal Patches Industry Growth and Trends Forecast to 2032

20 December 202592 pages

Choose your research edition.

Industry ResearchEstradiol Transdermal Patches Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Estradiol Transdermal Patches Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Estradiol Transdermal Patches Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Estradiol Transdermal Patches Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Estradiol Transdermal Patches Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Estradiol Transdermal Patches market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Estradiol Transdermal Patches is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Estradiol Transdermal Patches is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Estradiol Transdermal Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Estradiol Transdermal Patches include Novartis, Bayer Healthcare Pharmaceuticals, AbbVie, Women First Healthcare Inc, Watson Labs, Noven, Lumara Health and ANI Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Estradiol Transdermal Patches market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Estradiol Transdermal Patches market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Estradiol Transdermal Patches market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Estradiol Transdermal Patches.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Estradiol Transdermal Patches market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Estradiol Transdermal Patches Market by Company

Novartis

Bayer Healthcare Pharmaceuticals

AbbVie

Women First Healthcare Inc

Watson Labs

Noven

Lumara Health

ANI Pharmaceuticals

Estradiol Transdermal Patches Segment by Type

100 mg/day

25 mg/day

50 mg/day

75 mg/day

Estradiol Transdermal Patches Segment by Application

Male

Female

Estradiol Transdermal Patches Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Estradiol Transdermal Patches market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Estradiol Transdermal Patches and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Estradiol Transdermal Patches.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Estradiol Transdermal Patches manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Estradiol Transdermal Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 100 mg/day Table 2. Major Company of 25 mg/day Table 3. Major Company of 50 mg/day Table 4. Major Company of 75 mg/day Table 5. Global Estradiol Transdermal Patches Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Estradiol Transdermal Patches Sales by Type (2021-2026) & (k units) Table 7. Global Estradiol Transdermal Patches Sales Market Share in Volume by Type (2021-2026) Table 8. Global Estradiol Transdermal Patches Sales by Type (2021-2026) & (US$ Million) Table 9. Global Estradiol Transdermal Patches Sales Market Share in Value by Type (2021-2026) Table 10. Global Estradiol Transdermal Patches Price by Type (2021-2026) & (US$/unit) Table 11. Global Estradiol Transdermal Patches Sales by Type (2027-2032) & (k units) Table 12. Global Estradiol Transdermal Patches Sales Market Share in Volume by Type (2027-2032) Table 13. Global Estradiol Transdermal Patches Sales by Type (2027-2032) & (US$ Million) Table 14. Global Estradiol Transdermal Patches Sales Market Share in Value by Type (2027-2032) Table 15. Global Estradiol Transdermal Patches Price by Type (2027-2032) & (US$/unit) Table 16. North America Estradiol Transdermal Patches Sales by Type (2021-2026) & (k units) Table 17. North America Estradiol Transdermal Patches Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Estradiol Transdermal Patches Sales by Type (2021-2026) & (k units) Table 19. Europe Estradiol Transdermal Patches Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Estradiol Transdermal Patches Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Estradiol Transdermal Patches Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Estradiol Transdermal Patches Sales by Type (2021-2026) & (k units) Table 23. Latin America Estradiol Transdermal Patches Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Estradiol Transdermal Patches Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Estradiol Transdermal Patches Sales by Type (2021-2026) & (US$ Million) Table 26. Estradiol Transdermal Patches Industry Trends Table 27. Estradiol Transdermal Patches Industry Drivers Table 28. Estradiol Transdermal Patches Industry Opportunities and Challenges Table 29. Estradiol Transdermal Patches Industry Restraints Table 30. Global Estradiol Transdermal Patches Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Estradiol Transdermal Patches Revenue Market Share by Company (2021-2026) Table 32. Global Estradiol Transdermal Patches Sales by Company (2021-2026) & (k units) Table 33. Global Estradiol Transdermal Patches Sales Share by Company (2021-2026) Table 34. Global Estradiol Transdermal Patches Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Estradiol Transdermal Patches Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Estradiol Transdermal Patches Major Company Production Sites and Headquarters Table 37. Global Estradiol Transdermal Patches Company, Product Type & Application Table 38. Global Estradiol Transdermal Patches Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Estradiol Transdermal Patches by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Estradiol Transdermal Patches Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Estradiol Transdermal Patches Sales by Region (2021-2026) & (k units) Table 43. Global Estradiol Transdermal Patches Sales Market Share in Volume by Region (2021-2026) Table 44. Global Estradiol Transdermal Patches Sales by Region (2021-2026) & (US$ Million) Table 45. Global Estradiol Transdermal Patches Sales Market Share in Value by Region (2021-2026) Table 46. Global Estradiol Transdermal Patches Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Estradiol Transdermal Patches Sales by Region (2027-2032) & (k units) Table 48. Global Estradiol Transdermal Patches Sales Market Share in Volume by Region (2027-2032) Table 49. Global Estradiol Transdermal Patches Sales by Region (2027-2032) & (US$ Million) Table 50. Global Estradiol Transdermal Patches Sales Market Share in Value by Region (2027-2032) Table 51. Global Estradiol Transdermal Patches Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Estradiol Transdermal Patches Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Estradiol Transdermal Patches Sales by Application (2021-2026) & (k units) Table 54. Global Estradiol Transdermal Patches Sales Market Share in Volume by Application (2021-2026) Table 55. Global Estradiol Transdermal Patches Sales by Application (2021-2026) & (US$ Million) Table 56. Global Estradiol Transdermal Patches Sales Market Share in Value by Application (2021-2026) Table 57. Global Estradiol Transdermal Patches Price by Application (2021-2026) & (US$/unit) Table 58. Global Estradiol Transdermal Patches Sales by Application (2027-2032) & (k units) Table 59. Global Estradiol Transdermal Patches Sales Market Share in Volume by Application (2027-2032) Table 60. Global Estradiol Transdermal Patches Sales by Application (2027-2032) & (US$ Million) Table 61. Global Estradiol Transdermal Patches Sales Market Share in Value by Application (2027-2032) Table 62. Global Estradiol Transdermal Patches Price by Application (2027-2032) & (US$/unit) Table 63. North America Estradiol Transdermal Patches Sales by Application (2021-2026) & (k units) Table 64. North America Estradiol Transdermal Patches Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Estradiol Transdermal Patches Sales by Application (2021-2026) & (k units) Table 66. Europe Estradiol Transdermal Patches Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Estradiol Transdermal Patches Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Estradiol Transdermal Patches Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Estradiol Transdermal Patches Sales by Application (2021-2026) & (k units) Table 70. Latin America Estradiol Transdermal Patches Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Estradiol Transdermal Patches Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Estradiol Transdermal Patches Sales by Application (2021-2026) & (US$ Million) Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Estradiol Transdermal Patches Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Novartis Estradiol Transdermal Patches Product Portfolio Table 77. Novartis Recent Development Table 78. Bayer Healthcare Pharmaceuticals Company Information Table 79. Bayer Healthcare Pharmaceuticals Business Overview Table 80. Bayer Healthcare Pharmaceuticals Estradiol Transdermal Patches Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Bayer Healthcare Pharmaceuticals Estradiol Transdermal Patches Product Portfolio Table 82. Bayer Healthcare Pharmaceuticals Recent Development Table 83. AbbVie Company Information Table 84. AbbVie Business Overview Table 85. AbbVie Estradiol Transdermal Patches Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. AbbVie Estradiol Transdermal Patches Product Portfolio Table 87. AbbVie Recent Development Table 88. Women First Healthcare Inc Company Information Table 89. Women First Healthcare Inc Business Overview Table 90. Women First Healthcare Inc Estradiol Transdermal Patches Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Women First Healthcare Inc Estradiol Transdermal Patches Product Portfolio Table 92. Women First Healthcare Inc Recent Development Table 93. Watson Labs Company Information Table 94. Watson Labs Business Overview Table 95. Watson Labs Estradiol Transdermal Patches Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Watson Labs Estradiol Transdermal Patches Product Portfolio Table 97. Watson Labs Recent Development Table 98. Noven Company Information Table 99. Noven Business Overview Table 100. Noven Estradiol Transdermal Patches Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Noven Estradiol Transdermal Patches Product Portfolio Table 102. Noven Recent Development Table 103. Lumara Health Company Information Table 104. Lumara Health Business Overview Table 105. Lumara Health Estradiol Transdermal Patches Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Lumara Health Estradiol Transdermal Patches Product Portfolio Table 107. Lumara Health Recent Development Table 108. ANI Pharmaceuticals Company Information Table 109. ANI Pharmaceuticals Business Overview Table 110. ANI Pharmaceuticals Estradiol Transdermal Patches Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. ANI Pharmaceuticals Estradiol Transdermal Patches Product Portfolio Table 112. ANI Pharmaceuticals Recent Development Table 113. North America Estradiol Transdermal Patches Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 114. North America Estradiol Transdermal Patches Sales by Country (2021-2026) & (k units) Table 115. North America Estradiol Transdermal Patches Sales Market Share by Country (2021-2026) Table 116. North America Estradiol Transdermal Patches Sales Forecast by Country (2027-2032) & (k units) Table 117. North America Estradiol Transdermal Patches Sales Market Share Forecast by Country (2027-2032) Table 118. North America Estradiol Transdermal Patches Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Estradiol Transdermal Patches Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Estradiol Transdermal Patches Market Share by Country (2021-2026) Table 121. North America Estradiol Transdermal Patches Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Estradiol Transdermal Patches Market Share Forecast by Country (2027-2032) Table 123. Europe Estradiol Transdermal Patches Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 124. Europe Estradiol Transdermal Patches Sales by Country (2021-2026) & (k units) Table 125. Europe Estradiol Transdermal Patches Sales Market Share by Country (2021-2026) Table 126. Europe Estradiol Transdermal Patches Sales Forecast by Country (2027-2032) & (k units) Table 127. Europe Estradiol Transdermal Patches Sales Market Share Forecast by Country (2027-2032) Table 128. Europe Estradiol Transdermal Patches Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Estradiol Transdermal Patches Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Estradiol Transdermal Patches Market Share by Country (2021-2026) Table 131. Europe Estradiol Transdermal Patches Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Estradiol Transdermal Patches Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Estradiol Transdermal Patches Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Estradiol Transdermal Patches Sales by Country (2021-2026) & (k units) Table 135. Asia-Pacific Estradiol Transdermal Patches Sales Market Share by Country (2021-2026) Table 136. Asia-Pacific Estradiol Transdermal Patches Sales Forecast by Country (2027-2032) & (k units) Table 137. Asia-Pacific Estradiol Transdermal Patches Sales Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Estradiol Transdermal Patches Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Estradiol Transdermal Patches Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Estradiol Transdermal Patches Market Share by Country (2021-2026) Table 141. Asia-Pacific Estradiol Transdermal Patches Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Estradiol Transdermal Patches Market Share Forecast by Country (2027-2032) Table 143. Latin America Estradiol Transdermal Patches Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 144. Latin America Estradiol Transdermal Patches Sales by Country (2021-2026) & (k units) Table 145. Latin America Estradiol Transdermal Patches Sales Market Share by Country (2021-2026) Table 146. Latin America Estradiol Transdermal Patches Sales Forecast by Country (2027-2032) & (k units) Table 147. Latin America Estradiol Transdermal Patches Sales Market Share Forecast by Country (2027-2032) Table 148. Latin America Estradiol Transdermal Patches Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Estradiol Transdermal Patches Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Estradiol Transdermal Patches Market Share by Country (2021-2026) Table 151. Latin America Estradiol Transdermal Patches Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Estradiol Transdermal Patches Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Estradiol Transdermal Patches Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Estradiol Transdermal Patches Sales by Country (2021-2026) & (k units) Table 155. Middle East and Africa Estradiol Transdermal Patches Sales Market Share by Country (2021-2026) Table 156. Middle East and Africa Estradiol Transdermal Patches Sales Forecast by Country (2027-2032) & (k units) Table 157. Middle East and Africa Estradiol Transdermal Patches Sales Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Estradiol Transdermal Patches Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Estradiol Transdermal Patches Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East and Africa Estradiol Transdermal Patches Market Share by Country (2021-2026) Table 161. Middle East and Africa Estradiol Transdermal Patches Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa Estradiol Transdermal Patches Market Share Forecast by Country (2027-2032) Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Estradiol Transdermal Patches Distributors List Table 166. Estradiol Transdermal Patches Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Estradiol Transdermal Patches Image Figure 2. Global Estradiol Transdermal Patches Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Estradiol Transdermal Patches Market Size (2021-2032) & (US$ Million) Figure 4. Global Estradiol Transdermal Patches Sales (2021-2032) & (k units) Figure 5. 100 mg/day Image Figure 6. Global 100 mg/day Sales YoY Growth (2021-2032) & (k units) Figure 7. 25 mg/day Image Figure 8. Global 25 mg/day Sales YoY Growth (2021-2032) & (k units) Figure 9. 50 mg/day Image Figure 10. Global 50 mg/day Sales YoY Growth (2021-2032) & (k units) Figure 11. 75 mg/day Image Figure 12. Global 75 mg/day Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Estradiol Transdermal Patches Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Estradiol Transdermal Patches Market Share by Type 2025 VS 2032 Figure 15. North America Estradiol Transdermal Patches Sales Market Share in Volume by Type in 2025 Figure 16. North America Estradiol Transdermal Patches Sales Market Share in Value by Type in 2025 Figure 17. Europe Estradiol Transdermal Patches Sales Market Share in Volume by Type in 2025 Figure 18. Europe Estradiol Transdermal Patches Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Estradiol Transdermal Patches Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Estradiol Transdermal Patches Sales Market Share in Value by Type in 2025 Figure 21. Latin America Estradiol Transdermal Patches Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Estradiol Transdermal Patches Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Estradiol Transdermal Patches Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Estradiol Transdermal Patches Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Estradiol Transdermal Patches Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Male Image Figure 28. Global Male Sales YoY Growth (2021-2032) & (k units) Figure 29. Female Image Figure 30. Global Female Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Estradiol Transdermal Patches Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Estradiol Transdermal Patches Market Share by Application 2025 VS 2032 Figure 33. North America Estradiol Transdermal Patches Sales Market Share in Volume by Application in 2025 Figure 34. North America Estradiol Transdermal Patches Sales Market Share in Value by Application in 2025 Figure 35. Europe Estradiol Transdermal Patches Sales Market Share in Volume by Application in 2025 Figure 36. Europe Estradiol Transdermal Patches Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Estradiol Transdermal Patches Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Estradiol Transdermal Patches Sales Market Share in Value by Application in 2025 Figure 39. Latin America Estradiol Transdermal Patches Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Estradiol Transdermal Patches Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Estradiol Transdermal Patches Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Estradiol Transdermal Patches Sales Market Share in Value by Application in 2025 Figure 43. North America Estradiol Transdermal Patches Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Estradiol Transdermal Patches Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Estradiol Transdermal Patches Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Estradiol Transdermal Patches Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Estradiol Transdermal Patches Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Estradiol Transdermal Patches Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Estradiol Transdermal Patches Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Estradiol Transdermal Patches Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Estradiol Transdermal Patches Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Estradiol Transdermal Patches Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Estradiol Transdermal Patches Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Estradiol Transdermal Patches Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Estradiol Transdermal Patches Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Estradiol Transdermal Patches Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Estradiol Transdermal Patches Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Estradiol Transdermal Patches Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Estradiol Transdermal Patches Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Estradiol Transdermal Patches Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Estradiol Transdermal Patches Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Estradiol Transdermal Patches Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Estradiol Transdermal Patches Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Estradiol Transdermal Patches Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 100 mg/day
  • 25 mg/day
  • 50 mg/day
  • 75 mg/day
Applications
  • Male
  • Female
Companies covered
  • Novartis
  • Bayer Healthcare Pharmaceuticals
  • AbbVie
  • Women First Healthcare Inc
  • Watson Labs
  • Noven
  • Lumara Health
  • ANI Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Estradiol Transdermal Patches Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Estradiol Transdermal Patches Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Estradiol Transdermal Patches Market by Type
  6. 1.3.1 100 mg/day
  7. 1.3.2 25 mg/day
  8. 1.3.3 50 mg/day
  9. 1.3.4 75 mg/day
  10. 1.4 Global Estradiol Transdermal Patches Market Size by Type
  11. 1.4.1 Global Estradiol Transdermal Patches Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Estradiol Transdermal Patches Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Estradiol Transdermal Patches Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Estradiol Transdermal Patches Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Estradiol Transdermal Patches Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Estradiol Transdermal Patches Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Estradiol Transdermal Patches Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Estradiol Transdermal Patches Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Estradiol Transdermal Patches Industry Trends
  2. 2.2 Estradiol Transdermal Patches Industry Drivers
  3. 2.3 Estradiol Transdermal Patches Industry Opportunities and Challenges
  4. 2.4 Estradiol Transdermal Patches Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Estradiol Transdermal Patches Revenue (2021-2026)
  2. 3.2 Global Top Players by Estradiol Transdermal Patches Sales (2021-2026)
  3. 3.3 Global Top Players by Estradiol Transdermal Patches Price (2021-2026)
  4. 3.4 Global Estradiol Transdermal Patches Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Estradiol Transdermal Patches Major Company Production Sites & Headquarters
  6. 3.6 Global Estradiol Transdermal Patches Company, Product Type & Application
  7. 3.7 Global Estradiol Transdermal Patches Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Estradiol Transdermal Patches Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Estradiol Transdermal Patches Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Estradiol Transdermal Patches Tier 1, Tier 2, and Tier 3
4 Estradiol Transdermal Patches Regional Status and Outlook
  1. 4.1 Global Estradiol Transdermal Patches Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Estradiol Transdermal Patches Historic Market Size by Region
  3. 4.2.1 Global Estradiol Transdermal Patches Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Estradiol Transdermal Patches Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Estradiol Transdermal Patches Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Estradiol Transdermal Patches Forecasted Market Size by Region
  7. 4.3.1 Global Estradiol Transdermal Patches Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Estradiol Transdermal Patches Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Estradiol Transdermal Patches Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Estradiol Transdermal Patches by Application
  1. 5.1 Estradiol Transdermal Patches Market by Application
  2. 5.1.1 Male
  3. 5.1.2 Female
  4. 5.2 Global Estradiol Transdermal Patches Market Size by Application
  5. 5.2.1 Global Estradiol Transdermal Patches Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Estradiol Transdermal Patches Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Estradiol Transdermal Patches Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Estradiol Transdermal Patches Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Estradiol Transdermal Patches Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Estradiol Transdermal Patches Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Estradiol Transdermal Patches Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Estradiol Transdermal Patches Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Estradiol Transdermal Patches Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Estradiol Transdermal Patches Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Bayer Healthcare Pharmaceuticals
  8. 6.2.1 Bayer Healthcare Pharmaceuticals Company Information
  9. 6.2.2 Bayer Healthcare Pharmaceuticals Business Overview
  10. 6.2.3 Bayer Healthcare Pharmaceuticals Estradiol Transdermal Patches Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bayer Healthcare Pharmaceuticals Estradiol Transdermal Patches Product Portfolio
  12. 6.2.5 Bayer Healthcare Pharmaceuticals Recent Developments
  13. 6.3 AbbVie
  14. 6.3.1 AbbVie Company Information
  15. 6.3.2 AbbVie Business Overview
  16. 6.3.3 AbbVie Estradiol Transdermal Patches Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 AbbVie Estradiol Transdermal Patches Product Portfolio
  18. 6.3.5 AbbVie Recent Developments
  19. 6.4 Women First Healthcare Inc
  20. 6.4.1 Women First Healthcare Inc Company Information
  21. 6.4.2 Women First Healthcare Inc Business Overview
  22. 6.4.3 Women First Healthcare Inc Estradiol Transdermal Patches Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Women First Healthcare Inc Estradiol Transdermal Patches Product Portfolio
  24. 6.4.5 Women First Healthcare Inc Recent Developments
  25. 6.5 Watson Labs
  26. 6.5.1 Watson Labs Company Information
  27. 6.5.2 Watson Labs Business Overview
  28. 6.5.3 Watson Labs Estradiol Transdermal Patches Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Watson Labs Estradiol Transdermal Patches Product Portfolio
  30. 6.5.5 Watson Labs Recent Developments
  31. 6.6 Noven
  32. 6.6.1 Noven Company Information
  33. 6.6.2 Noven Business Overview
  34. 6.6.3 Noven Estradiol Transdermal Patches Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Noven Estradiol Transdermal Patches Product Portfolio
  36. 6.6.5 Noven Recent Developments
  37. 6.7 Lumara Health
  38. 6.7.1 Lumara Health Company Information
  39. 6.7.2 Lumara Health Business Overview
  40. 6.7.3 Lumara Health Estradiol Transdermal Patches Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Lumara Health Estradiol Transdermal Patches Product Portfolio
  42. 6.7.5 Lumara Health Recent Developments
  43. 6.8 ANI Pharmaceuticals
  44. 6.8.1 ANI Pharmaceuticals Company Information
  45. 6.8.2 ANI Pharmaceuticals Business Overview
  46. 6.8.3 ANI Pharmaceuticals Estradiol Transdermal Patches Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 ANI Pharmaceuticals Estradiol Transdermal Patches Product Portfolio
  48. 6.8.5 ANI Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Estradiol Transdermal Patches Sales by Country
  2. 7.1.1 North America Estradiol Transdermal Patches Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Estradiol Transdermal Patches Sales by Country (2021-2026)
  4. 7.1.3 North America Estradiol Transdermal Patches Sales Forecast by Country (2027-2032)
  5. 7.2 North America Estradiol Transdermal Patches Market Size by Country
  6. 7.2.1 North America Estradiol Transdermal Patches Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Estradiol Transdermal Patches Market Size by Country (2021-2026)
  8. 7.2.3 North America Estradiol Transdermal Patches Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Estradiol Transdermal Patches Sales by Country
  2. 8.1.1 Europe Estradiol Transdermal Patches Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Estradiol Transdermal Patches Sales by Country (2021-2026)
  4. 8.1.3 Europe Estradiol Transdermal Patches Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Estradiol Transdermal Patches Market Size by Country
  6. 8.2.1 Europe Estradiol Transdermal Patches Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Estradiol Transdermal Patches Market Size by Country (2021-2026)
  8. 8.2.3 Europe Estradiol Transdermal Patches Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Estradiol Transdermal Patches Sales by Country
  2. 9.1.1 Asia-Pacific Estradiol Transdermal Patches Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Estradiol Transdermal Patches Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Estradiol Transdermal Patches Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Estradiol Transdermal Patches Market Size by Country
  6. 9.2.1 Asia-Pacific Estradiol Transdermal Patches Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Estradiol Transdermal Patches Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Estradiol Transdermal Patches Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Estradiol Transdermal Patches Sales by Country
  2. 10.1.1 South America Estradiol Transdermal Patches Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Estradiol Transdermal Patches Sales by Country (2021-2026)
  4. 10.1.3 South America Estradiol Transdermal Patches Sales Forecast by Country (2027-2032)
  5. 10.2 South America Estradiol Transdermal Patches Market Size by Country
  6. 10.2.1 South America Estradiol Transdermal Patches Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Estradiol Transdermal Patches Market Size by Country (2021-2026)
  8. 10.2.3 South America Estradiol Transdermal Patches Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Estradiol Transdermal Patches Sales by Country
  2. 11.1.1 Middle East and Africa Estradiol Transdermal Patches Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Estradiol Transdermal Patches Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Estradiol Transdermal Patches Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Estradiol Transdermal Patches Market Size by Country
  6. 11.2.1 Middle East and Africa Estradiol Transdermal Patches Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Estradiol Transdermal Patches Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Estradiol Transdermal Patches Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Estradiol Transdermal Patches Value Chain Analysis
  2. 12.1.1 Estradiol Transdermal Patches Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Estradiol Transdermal Patches Production Mode & Process
  7. 12.2 Estradiol Transdermal Patches Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Estradiol Transdermal Patches Distributors
  10. 12.2.3 Estradiol Transdermal Patches Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst